These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31332514)

  • 21. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort.
    FitzHenry F; Eden SK; Denton J; Cao H; Cao A; Reeves R; Chen G; Gobbel G; Wells N; Matheny ME
    Pain Res Manag; 2020; 2020():5165682. PubMed ID: 32318129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer.
    Sindt JE; Odell DW; Dalley AP; Brogan SE
    Neuromodulation; 2020 Oct; 23(7):978-983. PubMed ID: 32459393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features.
    Davies A; Leach C; Butler C; Gregory A; Henshaw S; Minton O; Shorthose K; Batsari KM
    Pain; 2021 Jan; 162(1):309-318. PubMed ID: 32701649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer.
    Bull J; Bonsignore L; Massie L; Riggs A; Knotkova H; Wellman C; Portenoy R
    J Pain Symptom Manage; 2019 May; 57(5):e5-e8. PubMed ID: 30853551
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between opioid usage and rectal dysfunction in constipation: A cross-sectional study of 2754 patients.
    Vollebregt PF; Hooper RL; Farmer AD; Miller J; Knowles CH; Scott SM
    Neurogastroenterol Motil; 2020 Jul; 32(7):e13839. PubMed ID: 32167628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep quality with WHO Step III opioid use for cancer pain.
    Jakobsen G; Engstrøm M; Fayers P; Hjermstad MJ; Kaasa S; Kloke M; Sabatowski R; Klepstad P
    BMJ Support Palliat Care; 2019 Sep; 9(3):307-315. PubMed ID: 30018128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy.
    Fine PG; Chen YW; Wittbrodt E; Datto C
    Support Care Cancer; 2019 Feb; 27(2):687-696. PubMed ID: 30056531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies.
    Nielsen S; Degenhardt L; Hoban B; Gisev N
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):733-7. PubMed ID: 26693665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
    Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
    Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L; Diva U; Tummala R; Sostek M
    Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl.
    Leppert W; Nosek K
    Curr Pharm Des; 2019; 25(30):3216-3224. PubMed ID: 31333114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Patient-Provider Interactions Regarding the Burden and Treatment of Opioid-Induced Constipation in Adults with Chronic Noncancer Pain.
    Vallerand AH; Hendry S; Baldys E; Hu Y; Datto C
    Pain Med; 2019 May; 20(5):889-896. PubMed ID: 30125008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
    Corli O; Floriani I; Roberto A; Montanari M; Galli F; Greco MT; Caraceni A; Kaasa S; Dragani TA; Azzarello G; Luzzani M; Cavanna L; Bandieri E; Gamucci T; Lipari G; Di Gregorio R; Valenti D; Reale C; Pavesi L; Iorno V; Crispino C; Pacchioni M; Apolone G;
    Ann Oncol; 2016 Jun; 27(6):1107-1115. PubMed ID: 26940689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
    Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
    Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.